Zelira Therapeutics Ltd has released a press release.
Clinical Research Programme to Expand to Include Autism
Filed with ASX ·
6ix hasn’t read this filing yet.
Zelira Therapeutics Ltd. on 6ix
Earlier from Zelira Therapeutics
- Cleansing Prospectus
- Zelda Successfully Completes Capital Raising
- Zelda Enters Strategic Partnership with CannPal
- Clinical Trials to Commence in Chile
- New Licence Agreement
Later from Zelira Therapeutics
- March 2017 Quarterly Report
- Positive Results From Pre-Clinical Breast Cancer Studies
- Zelda Enters into Strategic Agreement with Knop Laboratories
- Expansion of Breast Cancer Research Collaboration
- Successful Results in Autism Observation Trial
Follow Zelira Therapeutics into a list and get an email when it puts out news.
Follow Zelira Therapeutics